Domača stranHLUN-A • CPH
add
H. Lundbeck A/S Class A
Prejšnji trg. dan.
35,95 kr
Dnevni razpon
35,80 kr - 35,95 kr
Letni razpon
27,10 kr - 41,70 kr
Tržna kapitalizacija
43,04 mrd. DKK
Povprečni obseg
62,23 tis.
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
CPH
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (DKK) | sep. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 5,72 mrd. | 15,55 % |
Stroški poslovanja | 3,67 mrd. | 23,76 % |
Čisti dohodek | 777,00 mio. | 14,94 % |
Čista dobičkovnost prihodkov | 13,58 | −0,51 % |
Earnings per share | 1,30 | 11,11 % |
EBITDA | 1,43 mrd. | 3,10 % |
Efektivna davčna stopnja | −6,15 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (DKK) | sep. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 8,32 mrd. | 95,90 % |
Skupna sredstva | 39,52 mrd. | 4,89 % |
Skupne obveznosti | 15,68 mrd. | 2,04 % |
Celoten lastniški kapital | 23,84 mrd. | — |
Shares outstanding | 996,15 mio. | — |
Razmerje P/B | 1,50 | — |
Donosnost sredstev | 6,11 % | — |
Donosnost kapitala | 8,67 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (DKK) | sep. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 777,00 mio. | 14,94 % |
Denar iz dejavnosti | 2,30 mrd. | 54,50 % |
Denar iz naložb | −101,00 mio. | −4,12 % |
Denar iz financiranja | −24,00 mio. | 97,05 % |
Neto sprememba denarnih sredstev | 2,17 mrd. | 270,77 % |
Prost denarni tok | 985,25 mio. | −28,86 % |
Vizitka
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.
Headquartered in Copenhagen, Denmark, Lundbeck has approximately 5,600 employees in more than 50 countries, and their products are registered in more than 100 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and the US.
Lundbeck is listed on the Copenhagen Stock Exchange.
Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations Wikipedia
Generalni direktor
Datum ustanovitve
14. avg. 1915
Spletno mesto
Zaposleni
5.500
